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ABSTRACT OF THE THESIS 
 
 
 
Development of a Risk Prediction Model for In-Hospital Cardiac Arrests 
Using Continuous Electrocardiographic Telemetry Monitoring Data 
 
by 
 
 
Duc Hong Do 
 
Master of Science in Clinical Research 
University of California, Los Angeles, 2018 
Professor Zhilin Qu, Chair 
 
 
Background: Many electrocardiographic (ECG) changes occur before in-hospital cardiac arrest (ICHA) 
due to pulseless electrical activity (PEA)/asystole. It is not known if these are unique to this period. 
 
Objective: Evaluate whether ECG changes provide predictive information for IHCA from PEA/asystole. 
 
Methods: We collected continuous ECG data from case and control patients. We selected three 
consecutive 3-hour blocks (block 3, 2, 1 in that order) preceding IHCA in cases and randomly in controls; 
only case block 1 immediately preceded IHCA. In each block, we measured dominant positive and 
negative trends in ECG parameters and determined the presence of arrhythmias. We also compared 
features between consecutive blocks. We created one random forest and two logistic regression models, 
and tested them on differentiating case vs. control patients (case block 1 vs. control block 1), and 
temporal relationship to ICHA (case block 1 vs. case block 2).  
 iii 
 
 
Results: We evaluated 77 cases (age 62.5±17.3, 57% male) and 1783 control patients (age 63.5±14.8, 
67% male). We found many significant differences in ECG trends between case and control block 1, 
particularly in QRS duration, QTc, RR, and ST. New episodes of atrial fibrillation and bradyarrhythmias 
were more common before ICHA. The optimal model developed using only ECG changes was the 
random forest, achieving an AUC of 0.810, 57.9% sensitivity, 95.7% specificity at differentiating case vs. 
control, and AUC 0.942, 88.3% sensitivity, 90.1% specificity at differentiating case block 1 vs. block 2.  
 
Conclusions: ECG parameters during the 3-hour window immediately preceding ICHA differ 
significantly from other time periods, and provides very good predictive information for IHCA.  
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INTRODUCTION 
In-hospital cardiac arrests (IHCA) remain a major health care problem, affecting over 250,000 patients in 
the United States annually, with fewer than 30% of these patients surviving to discharge. Over the past 
decade, there has been considerable interest in early intervention, giving rise to hospital rapid response 
teams and attempts at developing early warning systems. Despite widespread interest in and 
implementation of these systems, well-designed studies have failed to show a significant benefit(1-4).  
The use of threshold cutoffs(5), derived from population-based studies, to generate risk scores for IHCA 
does not account for individual patient level variations. In addition, for patients on medical-surgical 
floors, vital signs and labs, which form the backbone of many such systems, are only obtained every 4-24 
hours. This approach has little ability to detect rapid patient deterioration(6). On the other hand, 
electrocardiographic (ECG)/telemetry data is continuously acquired in many patients in intensive care 
units (ICU), stepdown units, and some medical-surgical floors. ECG parameters reflect many physiologic 
changes due to stressors; many intra-patient ECG changes including PR and QRS prolongation, ST 
changes, and bradyarrhythmias are seen in the 24 hours and particularly the one hour period before 
IHCA(7-9). However, it remains unknown whether these findings are sufficiently specific to the pre-
IHCA period to be useful features for cardiac arrest prediction. 
In this study, we evaluate whether the measurement of trends in ECG parameters, particularly in 
comparison to a patient’s baseline physiologic variations, and detection of new arrhythmias provides 
predictive information for IHCA from pulseless electrical activity (PEA) or asystole. 
 
 
 
 
 2 
 
MATERIAL AND METHODS 
We conducted a retrospective case-control study at the University of California, Los Angeles (UCLA) 
Ronald Reagan Medical Center, a 520-bed tertiary care hospital. Telemetry data was obtained by General 
Electric (GE) monitoring systems (GE Healthcare, Waukesha, WI), and pooled on a remote data server 
via Bedmaster (Excel Medical Electronics, Jupiter, FL). Signals were sampled at 240 Hz with 12-bit 
representation. Continuous electrocardiographic data was obtained using a standard 5 electrode 
configuration providing 4 ECG leads (I, II, III and precordial lead usually in the V2 position). A total of 
200 beds, including all 130 adult intensive care unit (ICU) beds, and 70 randomly selected medical–
surgical unit beds were monitored with the Bedmaster system at any one time. This study received 
approval from the institutional review board at UCLA. 
We evaluated all ‘code blues’ between April 2010 and March 2013, and included IHCA cases due to PEA 
or asystole in patients age ≥18 years, with telemetry data available for at least 6 consecutive hours prior to 
and including the onset of IHCA. We excluded cases where cardiac arrest (defined as lack of central 
pulse, apnea, and unresponsiveness) was not the primary reason for the code blue, patients with a do-not-
resuscitate order, primarily ventricular-paced rhythm, out-of-hospital cardiac arrest leading to current 
admission, IHCA in a procedural unit or operating room, and IHCA within the first 24 hours of a trauma 
admission. Only the first IHCA in any patient during a hospitalization was included. The time of cardiac 
arrest was determined by review of ECG data and marked at onset of asystole or initiation of chest 
compressions as visualized by chest compression artifact in cases of PEA. For each case, we extracted 
telemetry data for up to 24 hours prior to IHCA.  
Control patients were selected at random from the same units where code blue patients (not specifically 
patients who met all inclusion/exclusion criteria) were located at the time of IHCA and temporally spread 
across the study period. Criteria for selecting control patients included survival to discharge, no 
unplanned ICU transfers or code blues during the admission. Case patients who had another admission 
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which met those criteria were excluded as controls. For each control patient, we extracted the first 24 
hours of telemetry data available, since this was likely to be the period of greatest instability. 
Telemetry Data Processing 
Telemetry data was processed using a research ECG analysis program written by coauthor DM to obtain: 
1) a minute-by-minute time series of ECG parameters (PR interval, QRS duration, averaged QRS 
amplitude, ST segment height in lead II and V2, QTc, and RR) derived from a 5-minute signal-averaged 
beat obtained in a rolling window fashion, and 2) a time series of all consecutive RR intervals (Figure 1).  
The averaged beat-derived time series was processed with a series of filters to reduce noise and remove 
non-physiologic data from supraventricular arrhythmias or pacing. The RR time series, following removal 
of data points affected by excessive signal artifact, was processed to identify periods of atrial fibrillation 
(AF), second degree heart block (2° HB), and pauses greater than 3 seconds, using modifications of 
methods described by Lian et al(10) and Tsipouras et al(11) (see Supplemental Data for further details).   
Selection of Data Blocks 
Three consecutive 3-hour blocks (blocks 3, 2, 1 in that order) were selected for further analysis: in case 
patients these blocks immediately preceded IHCA while in control patients, these were selected at random 
within the extracted data. Hence, block 1 in cases is the only IHCA block (Figure 2).  
Data for each ECG parameter in each block was evaluated for adequacy of information (minimum 120 
data points available, out of a possible 180). If the minimum number of points was not available, the 
block for that ECG parameter was excluded from analysis. We found that PR interval blocks were the 
most commonly excluded parameter due to AF or excessive baseline artifact. 
Trend Determination 
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For the averaged beat data, in each block of data, we determined the dominant positive and negative trend 
for each ECG parameter (Figure 3, Supplemental Methods). All time series processing was performed 
using Matlab 2017b (Mathworks, Natick, MA).  
Statistical Analysis 
The following features, all continuous variables, were calculated from the averaged beat data for each 
ECG parameter in each block: 
1. Change in dominant positive and negative trends in block n (Δyn+, Δyn-). This was calculated by 
subtracting the maximal and minimal value for the trend.  
2. Slope of the dominant positive and negative trends (Δyn+/Δxn+, Δyn-/Δxn-). This was calculated by 
dividing the change over the duration.  
3. Difference in dominant positive and negative trend change and slope between a patient’s block n 
and immediately preceding block (n-1). Four values were calculated: difference in dominant 1) 
positive change (Δyn-(n-1)+), 2) negative change (Δyn-(n-1)-), 3) positive slope (Δyn+/Δxn+- Δy(n-
1)
+/Δx(n-1)+), and 4) negative slope (Δyn-/Δxn – Δy(n-1)-/Δx(n-1)-).   
Continuous variables were assessed for normality using the Shapiro-Wilks test. Comparisons between 
groups were performed using Wilcoxon rank-sum test given non-normality of many variables. For the 
presence of AF, 2° HB, and pauses, we calculated an indicator variable for the presence of those 
arrhythmias in block n, and a second for the presence of those arrhythmias in block n but not block (n-1).  
Next, we divided the case and control block 1 into a stratified 75% model development and 25% 
validation set. Using the development set, we performed univariate logistic regression analyses, and 
retained any variable with p<0.05 for use in multivariable model development. Missing values were 
imputed using multiple imputations. We created 3 models: logistic regression with backward stepwise 
regression, forward stepwise regression, and random forest with 10000 trees. We evaluated each model 
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on the validation set by using the area under the curve (AUC) and sensitivity for classifying a block as 
IHCA while maintaining a low false positive rate (FPR).  
We performed further testing of model robustness by first setting a classification threshold where FPR on 
the validation set was approximately 5% and evaluated the sensitivity and specificity on case block 1 vs. 
case block 2 (temporal differentiation of ICHA detection), validation case block 1 vs. control block 2, 
case block 2 vs. validation control block 1, case block 2 vs. control block 2.  
Univariate analyses were performed using JMP 13 (SAS Institute, Cary, NC). Multivariable analyses 
were performed using R v3.4.4(12,13). A two-sided p<0.05 was considered statistically significant. For 
univariate analyses, adjustment for multiple comparison testing was evaluated by calculating q-values to 
estimate the false discovery rate with q<0.05 considered significant(14).  
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RESULTS 
We identified 77 case (mean age 62.5±17.3, 57% male) and 1783 control patients (mean age 63.5±14.8, 
67% male). The primary causes of IHCA in the case patients were respiratory in 44 (57%), multiorgan 
failure in 13 (17%), and metabolic acidosis in 12 (16%). Sixty-eight (88%) of IHCA occurred in the ICU 
setting, 53 (69%) had ROSC, and 19 (25%) survived to discharge (Table 1).  
Univariate analysis 
All block 1 dominant trend changes and slopes were right skewed in their distribution. Intra-patient 
comparisons between block 1 and block 2 for each variable were normally distributed; in controls these 
distributions were centered near zero. On univariate analysis, we found 39/62 variables, both block 1 
measures and block1-block2 comparisons, that were significantly associated with IHCA, particularly 
those related to QRSd, QTc, RR, ST lead II, and ST lead V2 (Table 2, Supplemental Table 1). For these 
ECG parameters, increased change in both positive and negative directions were associated with IHCA.  
Any AF, 2° HB, or pauses in block 1 was found in 35% vs. 20% (OR 2.0, CI1.2-3.3), 38% vs. 18% (OR 
2.6, CI 1.6-4.2), and 32% vs 20% (OR 1.8, CI 1.1-2.9) of cases vs. controls, respectively. Having any AF, 
2° HB, or pauses in block 1 but not block 2 was found in 14% vs. 3% (OR 4.4, CI 2.2-8.8), 27% vs 3% 
(OR 3.8, CI 2.2-6.3), 23% vs 23% (OR 2.0, CI 1.2-3.5) of cases vs. controls, respectively (Table 2).  
Significant differences in 12/62 variables for case vs. control block 2 were found(Supplemental Table 2). 
After adjustment for multiple comparisons, all variables for block 1 with p<0.05 remained significant 
with q<0.05 compared to none for block 2. 
Multivariable analyses   
Both logistic regression models derived by backwards and forwards stepwise regression achieved similar 
AUC on the development set (0.770 vs 0.778) and validation set (0.841 vs 0.849) (Table 3, Figure 4). In 
both models, the presence of AF and 2° HB in block n but not block n-1, QRSd Δyn+, QRSd Δyn+/Δxn+, 
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QTc Δyn-, RR Δyn-(n-1)+, and ST Lead V2 Δyn-(n-1)- were significantly associated with the risk of IHCA 
(Supplemental Table 3). 
The random forest model achieved an AUC of 0.730 on the development set and 0.810 on the validation 
set. The 5 most important variables in this model were: RR Δyn-(n-1)+, QTc Δyn-, QTc Δyn-(n-1)-, ST Lead V2 
Δyn-(n-1)+, and QRSd Δyn+ (Supplemental Figure 2).  
Evaluating the models based on sensitivity achieved with a low FPR, the random forest model performed 
best, achieving a sensitivity of 47.3%, 52.6%, and 57.9% with a FPR of 2.5%, 5%, and 10% respectively 
(Table 3). Using an optimal threshold determined by maintaining an approximately 5% FPR, the random 
forest model was the best at distinguishing block 1 from block 2 in cases (AUC 0.939, sensitivity 89.6%, 
specificity 90.1%). All models, as expected, performed poorly at differentiating case block 2 from either 
control block 1 or block 2 (Table 3).  
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DISCUSSION 
ECG “biomarkers” as predictors of adverse events or outcomes have long fascinated clinicians. Heart rate 
variability and microvolt T-wave alternans are prominent examples of ECG-derived features which have 
been associated with a variety of adverse outcomes in a diverse group of patients ranging from those with 
prior myocardial infarction to cardiomyopathy and even post-menopausal women(15-17). However, the 
actual impact of these measures remain poorly defined; the association is clear but there are no clear 
therapeutic targets or feedback for clinicians, leaving these primarily as research tools (18-20).  
A significant problem with most ECG “biomarkers” stems from their static nature as a snapshot in time, 
ignoring the inherent dynamic nature of even basic ECG parameters(21). While clinicians intuitively 
assess patient status by evaluating for changes from baseline, this approach has not been translated 
utilized in the development of ECG “biomarkers” for risk prediction, including those used for continuous 
ECG monitoring. While making rule-based (threshold-based) evaluations on single time-point data such 
as the 12-lead ECG is reasonable, studies have long shown the importance of comparison to prior ECGs 
to make important clinical diagnoses and management decisions(22-24). Hence, for ECG to be a useful 
risk prediction modality, models should reflect the dynamic nature of ECG and provide a closed feedback 
loop (Figure 5).  
In this study, we show that: 1) it is feasible to trend changes over time in clinically relevant ECG 
parameters and arrhythmias using continuous ECG monitoring data, 2) trends in ECG parameters and 
arrhythmias differ significantly in the 3-hour window pre-IHCA as compared to controls and prior 3-hour 
windows in case patients, and 3) this information can be leveraged in predictive models for IHCA due to 
PEA or asystole. To our knowledge, this is the first study to evaluate the use of continuous ECG 
monitoring for the prediction of ICHA from PEA and asystole, which make up around 80% of total 
ICHA(25). 
Utilizing trends in ECG analysis 
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The evaluation of trends in ECG parameters on continuous recordings, rather than absolute thresholds, 
allows for individualization of clinical risk prediction based on the patient’s baseline 
electrocardiogram(9,26). For example, 0.1mV ST depression in a patient with baseline left ventricular 
hypertrophy confers a significantly lower risk compared to a patient with a baseline normal ST segment. 
While some physiologic fluctuation in ECG parameters are expected even in resting normal healthy 
subjects(21,27), we found that the degree of fluctuations observed prior to IHCA, particularly in the ST 
segment and QRS duration, exceed those normally observed.  
The evaluation of trends in both the positive and negative directions allow for detection of different types 
of physiologic disturbances associated with different causes of cardiac arrest (Figure 6). For example, 
while QRS prolongation by intraventricular conduction delay can reflect progressive ischemia(28), a 
decrease in measured QRS duration is likely artefactual as a result of decreasing QRS amplitude(29), 
reported in septic shock states(30). We previously showed in a case control study with 27 bradyasystole 
cases and 304 controls that combinations of various ECG trend changes could be used to obtain as much 
as 33% sensitivity with 100% specificity(9). However, bradyasystole cases represent an ideal scenario 
where trends in many ECG parameters change monotonically in one direction over a long period leading 
up to ICHA, which is not true of the larger group of PEA cases.      
Therefore, we developed further features to compare trends and arrhythmias with those during prior time 
periods. This is based on the rationale that some ECG parameters, particularly RR interval and ST 
segments, can fluctuate significantly even in healthy states with exertion/rest and other stressors. Hence, 
differentiation of physiologic vs. pathologic changes (eg. differentiating a slowing heart rate preceding 
many types of PEA compared to physiologic slowing of heart rate(31,32)), can be better deduced by 
comparing magnitudes and rates of change to those in earlier time periods when the patient was known to 
be stable (Figure 7).  
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Similarly, second degree HB, either AV or sinoatrial, occurs commonly during sleep, particularly in 
patients with sleep apnea, and hence is unlikely to be predictive unless they are of new onset(33). New 
episodes of AF have been associated with increased ICU length of stay and hospital mortality, but not AF 
in patients with a prior history(34). While we found that pauses of greater than 3 seconds were 
proportionately more common in the pre-ICHA period, the baseline rate in control patients is high, likely 
reflecting the limitations of arrhythmia detection methods that depend only on RR intervals due to their 
susceptibility to frequent ectopic beats, artifact, and low amplitude QRS complexes(35).  
Utilization of ECG findings in the prediction of IHCA 
In this study, we show that ECG changes in a 3-hour window alone have a very good ability to predict an 
imminent IHCA. This finding is independent of commonly used criteria such as vital signs and laboratory 
values(36).  
While logistic regression has been the standard method of risk prediction development, it assumes that 
risk factors (ECG metrics in our study) are additive(37). Given the inherent correlated nature of the 
positive and negative trend measure for a particular ECG parameter and the potential for different types of 
cardiac arrest to present predominantly with one or the other (Figure 6), logistic regression models may 
perform poorly due to model instability. On the other hand, non-linear classifiers such as the random 
forest perform better with such classification problems(38), at the cost of becoming a “black box”. 
In this study, while the AUC achieved by the logistic regression models were slightly superior to that of 
the random forest model, it must be considered that relatively few patients suffer IHCA and therefore 
models with low FPR for similar sensitivity achieved are preferred to prevent excessive false alarms. 
Using this criteria, the random forest model performed best, attaining 57.9% sensitivity with 95.7% 
specificity at the selected threshold. The random forest model, furthermore, showed excellent temporal 
discriminatory ability with an 89.6% sensitivity and 90.1% specificity at distinguishing block 1 vs. block 
2.  
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In practice, ECG metrics can play a complementary role to predictive algorithms that combine multiple 
data streams including demographic, vital sign, and laboratory data using a Bayesian approach(39). 
Whereas the intermittently collected data for vital signs and laboratory data can predict the “at-risk” 
patient, ECG changes, which predominantly occur in the last hour preceding ICHA, can help pinpoint the 
patient at impending risk of IHCA or who is rapidly deteriorating from an unanticipated event.  
Limitations 
The number of ICHA cases used in the derivation of this model is small and predominantly from ICU 
patients, potentially introducing bias towards the findings seen in this particular sample patient 
population. This in large part represents the difficulties of acquiring high quality continuous ECG data 
due to limitations from a data acquisition and information technology standpoint. Despite the innovations 
in ambulatory ECG monitoring with miniaturization, accessibility, and data storage, there has been little 
transformation in inpatient telemetry monitoring systems, driven by a vicious cycle of lack of data 
availability to develop useful predictive models, feeding a lack of sufficient clinical application(40) to 
drive innovation in accessibility and data storage.   
It should be noted, however, that cardiac arrest due to respiratory failure, the most common cause of 
PEA/Asystole in a general hospital population, also made up the largest group of cases in our study(41).  
Due to the small number of cases, we also were unable to use an independent test set to validate our 
models which can lead to overestimation of the model’s predictive power. However, further testing using 
block 2 data showed performance that was as expected. The positive predictive value is also a very 
important characteristic to consider in light of the pervasive problem of alarm fatigue(35), but difficult to 
estimate from an unbalanced-sample case-control study. 
In addition, we have not investigated other potential ECG parameters such as heart rate variability, the use 
of different detection window durations, and concurrent changes in 2 or more ECG parameters. These 
will be investigated as part of future studies. 
 12 
 
CONCLUSIONS 
Trends in ECG parameters, particularly in QRS duration, QTc, ST height, and RR, differ significantly 
between a 3-hour window immediately preceding ICHA from PEA or asystole compared to other 3-hour 
windows in both case and control patients. New episodes of AF and second degree heart block are also 
more common immediately prior to ICHA.  
Using ECG changes alone, we created a random forest model with AUC 0.810 on an independent 
validation set with 57.9% sensitivity achieved with 4.3% false positive rate. Using this threshold, the 
model was able to distinguish between the final 3-hour block preceding IHCA and the preceding 3-hour 
block with an AUC of 0.939, 89.6% sensitivity and 90.1% specificity. This study supports the feasibility 
of utilizing ECG changes over time in predictive models for IHCA. 
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FIGURE 1 
Processing of data and model development. Block n-1 refers to the block that precedes block n 
temporally (eg. Block 2 which precedes block 1, or block 3 which precedes block 2).  
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FIGURE 2 
Block selection example. Three consecutive 3-hour blocks are selected in both case and control patients. 
For cases, the blocks immediately precede in-hospital cardiac arrest (IHCA) (Panel A). In controls, the 
blocks are randomly selected (Panel B). Only block 1 in cases is associated with IHCA. While only PR 
interval data is shown in this example, all ECG parameters for the subject are evaluated in the same 
blocks. 
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FIGURE 3 
Dominant trend determination. The direction of change at each point is calculated by robust linear 
fitting (Panel A). Blue denotes positive trends and red denotes negative trends. Next short segments 
flanked by longer segments with opposite directionality are merged with the more dominant trend to 
remove minor fluctuations. Panel B shows the resultant dominant trends after a short negative trend 
segment is merged with the longer positive trend segment. The dominant trend in either direction is then 
determined by the trend in that direction with the longest duration.  
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FIGURE 4 
Receiver Operating Characteristics Curves for the Validation Set.  Curves are shown for 3 
multivariable models with their area under the curve (AUC): Panel A) Logistic regression with backward 
stepwise regression, B) Logistic regression with forward stepwise regression, C) Random forest with 
10,000 trees. The (X) marks the threshold chosen based on a specificity of approximately 95%.  
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FIGURE 5 
Optimal Continuous ECG Risk Prediction Model that provides a closed feedback loop, is updated 
continuously, and leverages the dynamic nature of ECG to provide personalized risk prediction. 
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FIGURE 6 
Patterns of Electrocardiographic Parameter Changes by Cause of Cardiac Arrest. The different 
panels show block 1 (final 3 hours before cardiac arrest) in 7 case patients, with the determined cause of 
the cardiac arrest. Graphs from top to bottom show trends in RR, QRS duration, ST lead II, and ST lead 
V2. The y-axis scaling is the same for a parameter across all cases. Positive (blue) and negative (red) 
trends are shown with the dominant trends for each block denoted by wider points. Similar patterns can be 
seen within cases from the same cause of arrest: eg. panels A, B, and C both show shortening of the RR 
followed by terminal prolongation of RR, with similar patterns of ST changes also seen in panels A and 
B. Different patterns can be noted despite similar determined cause of cardiac arrest (eg. Panel D vs. A, 
B, C). Unknown causes of cardiac arrest can potentially be matched to cases with known causes to 
determine possible cause of arrest (eg. Panels F and G).    
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FIGURE 7 
Comparison of Electrocardiographic Parameter Changes Over Time. RR and ST height in lead II 
data for a patient with cardiac arrest due to respiratory failure. From left to right, the graphs show 1. Each 
parameter over the 24 hour period preceding in-hospital cardiac arrest (IHCA) with the selected blocks 
labeled, 2. Block 3 (9 to 6 hours before IHCA), 3. Block 2 (6 to 3 hours before ICHA), 4. Block 1 (3 to 0 
hours before ICA). A similar scaling is used for all blocks. Positive (blue) and negative (red) trends are 
shown with the dominant trends for each block denoted by wider points. Fluctuations in the RR and ST 
are noted in all blocks, which is expected. However, comparison between block 1 and the other blocks, 
particularly the immediately preceding block, shows a greater degree of change for both RR and ST in the 
negative direction in block 1. 
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TABLE 1: DEMOGRAPHICS 
 Case (n = 77) Control (n = 1783) 
Age 62.5±17.3 63.5±14.8 
Male 44 (57%) 1201 (67%) 
ICU  68 (88%) 1322 (75%) 
Arrest characteristics   
 ROSC 53 (69%)  
 STD 19 (25%)  
Arrest Cause   
 Respiratory – unintubated 23 (29%)  
 Respiratory - intubated 11 (14%)  
 Metabolic acidosis 12 (16%)  
 Hemorrhagic shock 3 (4%)  
 Cardiogenic shock 5 (6%)  
 Distributive shock 1 (1%)  
 Myocardial infarction 1 (1%)  
 Multiorgan failure 13 (17%)  
 Unknown 8 (10%)  
Abbreviations. ROSC: return of spontaneous circulation, STD: survive to discharge 
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TABLE 2: ELECTROCARDIOGRAPHIC PARAMETER SUMMARY 
 Case (n = 77) Control (n = 1783) p-value‡ 
Arrhythmias, n(%) 
 AF, any in block 1 27 (35%) 373 (20%) 0.0067 
 AF, present block 1 not block 2 11 (14%) 64 (3%) 0.0002 
 2° HB, any in block 1 29 (38%) 332 (18%) 0.0002 
 2° HB, present block 1 not block 2 21 (27%) 162 (3%) <0.0001 
 Pauses, any in block 1 25 (32%) 376 (20%) 0.0242 
 Pauses, present block 1 not block 2 18 (23%) 229 (12%) 0.0153 
Trend Slope (Δy1/Δx1)†, median (IQR) 
 QRS Amplitude Averaged + (µV/hr) 320 (115 – 670) 312 (138 – 627) NS 
 QRS Amplitude Averaged - (µV/hr) 271 (118 – 684) 285 (137 – 608) NS 
 PR Interval + (ms/hr)* 6.3 (3.7 – 13.4) 6.7 (3.6 – 12.6) NS 
 PR Interval - (ms/hr)* 6.5 (3.3 – 20.2) 6.7 (3.7 – 13.4) NS 
 QRS Duration + (ms/hr) 6.3 (2.4 – 13.7) 4.2 (1.8 – 8.6) 0.0134 
 QRS Duration - (ms/hr) 5.4 (2.7 – 13.7) 3.7 (1.6 – 8.1) 0.0002 
 QTc + (ms/hr) 16.7 (9.0 – 38.0) 13.9 (7.6 – 27.5) NS 
 QTc - (ms/hr) 15.6 (8.5 – 48.5) 13.3 (6.9 – 25.5) 0.0238 
 RR + (ms/hr) 40.8 (26.3 – 77.2) 52.8 (27.2 – 98.2) NS 
 RR - (ms/hr) 40.9 (12.9 – 90.7) 53.8 (25.6 – 112.9) NS 
 ST Lead II + (µV/hr) 28.6 (13.1 – 68.3) 15.0 (7.8 – 29.0) 0.0023 
 ST Lead II - (µV/hr) 30.5 (14.0 – 61.5) 15.0 (8.0 – 30.4) <0.0001 
 ST Lead V2 + (µV/hr) 17.5 (6.9 – 44.8) 10.5 (5.5 – 19.5) 0.0029 
 ST Lead V2 - (µV/hr) 16.8 (6.6 – 34.0) 10.5 (5.3 – 20.7) 0.0389 
Trend Slope Comparison (Δy1/Δx1 – Δy2/Δx2) †, median (IQR) 
 QRS Amplitude Averaged + (µV/hr) 69 (-183 – 323) 10 (-212 – 243) NS 
 QRS Amplitude Averaged - (µV/hr) 53 (-175 – 317) -4 (-187 – 203) NS 
 PR Interval + (ms/hr)* 0.0 (-2.6 – 3.4) 0.2 (-4.8 – 5.1) NS 
 PR Interval - (ms/hr)* 1.0 (-2.9 – 8.3) 0.2 (-4.8 – 5.0) NS 
 QRS Duration + (ms/hr) 1.4 (-1.7 – 10.3) 0 (-3.7 – 3.9) 0.008 
 QRS Duration - (ms/hr) 2.4 (-1.0 – 6.1) 0.1 (-3.5 – 3.7) <0.0001 
 QTc + (ms/hr) 2.2 (-7 – 22.6) 0.3 (-11.0 – 11.3) NS 
 QTc - (ms/hr) -0.3 (-10.2 – 21.2) 0.4 (-8.9 – 10.7) NS 
 RR + (ms/hr) 5.3 (-23.5 – 30.9) 3.3 (-31.8 – 38.3) NS 
 RR - (ms/hr) 1.4 (-13.8 – 37.9) 0.1 (-42.2 – 38.1) NS 
 ST Lead II + (µV/hr) 6.3 (-8.2 – 32.9) -0.4 (-11.5 – 11.1) 0.0164 
 ST Lead II - (µV/hr) 4.5 (-8.4 – 26.4) -0.2 (-11.7 – 11.1) 0.0023 
 ST Lead V2 + (µV/hr) 3.1 (-8.6 – 14.2) -0.1 (-7.9 – 7.7) 0.0355 
 ST Lead V2 - (µV/hr) 0.8 (-7.8 – 16.8) 0.0 (-8.2 – 7.0) NS 
Trend Change (Δy1) †, median (IQR) 
 QRS Amplitude Averaged + (µV) 89 (43 – 180) 86 (47 – 158) NS 
 QRS Amplitude Averaged - (µV) 106 (58 – 190) 85 (48 – 143) 0.0191 
 PR Interval + (ms)* 8 (5 – 14.5) 7 (4 – 14) NS 
 PR Interval - (ms)* 8 (4 – 17) 7 (4 – 14) NS 
 QRS Duration + (ms) 9.5 (3 – 16) 4 (2 – 8) <0.0001 
 QRS Duration - (ms) 7.5 (3 – 13) 5 (2.8 – 8) 0.0015 
 QTc + (ms) 22.6 (11.7 – 41.1) 14.6 (8.5 – 26.7) 0.0017 
 QTc - (ms) 30.1 (11.2 – 57.3) 14.4 (9.0 – 26.0) <0.0001 
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 RR + (ms) 72 (32 – 138) 61 (32 – 103) 0.0035 
 RR - (ms) 45 (19 – 123) 58 (31 – 105) NS 
 ST Lead II + (µV) 34 (15 – 70) 16 (9 – 29.8) <0.0001 
 ST Lead II - (µV) 34.5 (16.5 – 74) 16 (9 – 29) <0.0001 
 ST Lead V2 + (µV) 20 (8 – 41) 11 (6 – 20) 0.0004 
 ST Lead V2 - (µV) 20 (9 – 42) 11 (6 – 20) <0.0001 
Trend Change Comparison (Δy1-2) †, median (IQR) 
 QRS Amplitude Averaged + (µV) 17 (-46 – 92) 0 (-59 – 61) NS 
 QRS Amplitude Averaged - (µV) 0 (-35 – 122) 0 (-42 – 49) 0.0020 
 PR Interval + (ms)* 0 (-4 – 3) 0 (-5 – 4) NS 
 PR Interval - (ms)* 1 (-2.75 – 7) 0 (-4 – 4) NS 
 QRS Duration + (ms) 2 (-1 – 12) 0 (-3 – 3) <0.0001 
 QRS Duration - (ms) 1.5 (-1 – 5.75) 0 (-3 – 3) 0.0002 
 QTc + (ms) 7.0 (-5.8 – 24.9) 0.7 (-8.3 – 9.3) 0.0268 
 QTc - (ms) 5.6 (-7.4 – 36.3) -0.20 (-8.5 – 8.2) 0.0024 
 RR + (ms) 26 (-13 – 86) 1 (-33 – 37) <0.0001 
 RR - (ms) 8 (-21 – 63) 2 (-31 – 35.5) <0.0001 
 ST Lead II + (µV) 9 (-7 – 50.5) 0 (-10 – 10) 0.0008 
 ST Lead II - (µV) 5 (-9 – 24.5) 0 (-10 – 10) 0.0004 
 ST Lead V2 + (µV) 4 (-3.25 – 19.5) 0 (-7 – 6) 0.0175 
 ST Lead V2 - (µV) 7.5 (-1.5 – 26) 0 (-6 – 7) 0.0007 
*Reported where measureable given this is not measureable in atrial fibrillation 
†For each row, + denotes the measure for the dominant positive trend, and – denotes the measure for 
the dominant negative trend for that ECG parameter. All negative trend change and slope 
measurements are reported as the absolute value.  
‡ All univariate comparisons with p-value < 0.05 were also significant at q-value < 0.05, which corrects 
for false discovery rate due to multiple hypothesis testing 
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TABLE 3: MULTIVARIATE MODEL PERFORMANCE 
 Logistic Regression – 
Backward Stepwise 
Logistic Regression – 
Forward Stepwise 
Random Forest 
Development Set (Case block 1 vs. Control block 1) 
 AUC 0.770 0.779 0.730 
Validation Set (Case block 1 vs. Control block 1) 
 AUC 0.841 0.849 0.810 
 Sensitivity, FPR 2.5% 21.1% 31.5% 36.8% 
 Sensitivity, FPR 5.0% 42.1% 42.1% 57.9% 
 Sensitivity, FPR 10.0% 47.4% 52.6% 63.2% 
Validation Set Performance at Selected Threshold 
 Sensitivity 47.4% 52.6% 57.9% 
 Specificity 94.3% 93.2 % 95.7% 
Test* – All Case Block 1 vs. Case Block 2  
 AUC 0.764 0.761 0.942 
 Sensitivity 37.7% 45.5% 88.3% 
 Specificity 91.5% 91.5% 90.1% 
Test* – Validation Set Case Block 1 vs. Control Block 2  
 AUC 0.822 0.849 0.853 
 Sensitivity 47.4% 52.6% 57.9% 
 Specificity 95.2% 94.5% 95.6% 
Test* – Case Block 2 vs. Validation Set Control Block 1  
 AUC 0.519 0.530 0.577 
 Sensitivity 8.5% 8.5% 9.9% 
 Specificity 94.3% 93.2 % 95.7% 
Test* – Case block 2 vs. Control block 2 
 AUC 0.528 0.538 0.593 
 Sensitivity 8.5% 8.5% 9.9% 
 Specificity  95.2% 94.5% 95.6% 
*All sensitivity and specificities are reported at the selected threshold 
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SUPPLEMENTAL METHODS 
Averaged Beat-derived ECG Parameter Filter Details: 
1. A median 2k+1 filter (k = 7): each time point was replaced with the median value of 15 points 
centered around that time point. The median filter is commonly used to reduce artifacts and 
outliers while preserving signal. The larger the k value, the greater the decrease in artifact but this 
comes at the cost of signal loss and increase in time delay. A filter size of 15 (k=7) was found to 
have reasonable tradeoff in our data (Supplemental Figure 1A). 
2. Tachyarrhythmia filter: the post-median filter RR interval time series was processed minute by 
minute to look for data points that exceeded 115% of the maximum of the preceding 20 points, or 
was 85% less than the minimum of the preceding 15 points. Each such point was flagged; N flags 
resulted in N+1 segments. If the mean RR for each segment was less than 80% of the mean of the 
entire RR time series (ie. segment HR exceeded 20% of the mean HR), the particular segment 
was flagged as a tachyarrhythmia block. PR interval, P wave duration, QTc, and RR data were 
removed for tachyarrhythmia blocks given the lack of comparability to non-tachyarrhythmia data 
for the purposes of trend analysis (Supplemental Figure 1B).   
3. Pacer-dependence filter: this filter identifies extended periods of extremely constant (invariable) 
HR, which is not physiologic. An extended constant HR was defined as lasting at least 120 
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consecutive HR data points. Thus, all 120 consecutive data point windows were processed to 
check for invariability. The median value of these 120s data points were subtracted from each of 
the 120 HR values. If the maximal absolute difference of these 120 differences were less than 
0.12 heart beats, then the 120-data point window was extended downstream one data point at a 
time, undergoing the same iterative checks as described above, until the largest window of 
invariability was identified. Corresponding metric data was dropped as pacing would artificially 
change the ECG metric of interest (Supplemental Figure 1C).  Multiple windows of complete 
pacer dependence could be identified in a single patient. The minimum of 120 data points and the 
0.12 maximal allowable heart rate difference were chosen purposefully to be extremely stringent 
to avoid wrongfully eliminating non-paced data. 
4. After the heart rate based filters, all metrics of interest, except ST, were processed through a 
continuity filter based on the assumption that changes to ECG metrics should be gradual and that 
large jumps are most likely secondary to artifacts and/or noise. A histogram was created with 10 
equal sized bins. Data points belonging to the highest frequency bin were defined as “modes”. 
Continuity check was conducted in both a forwards and backwards fashion starting at each 
“mode”. Marching point by point, if a value was greater than 115% of the maximum or less than 
85% of the minimum of the previous 20 continuous points, that value was defined as 
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discontinuous. Performing the check both forwards and backwards and from multiple starting 
points, the “modes”, ensured that dropped values fail to meet the continuity criteria from multiple 
angles (Supplemental Figure 1D).  
Dominant trend determination 
For the averaged beat data, in each block of data, we determined if the slope at each data point was 
positive or negative by performing robust linear fitting of 51 data points centered at the point of interest. 
Consecutive points with the same slope directionality were joined to form segments. Small segments 
flanked by larger segments of the opposite slope sign were merged into the larger segment. The dominant 
positive and negative trends, defined as the trend with the longest consecutive number of data points with 
positive and negative slopes respectively, were then determined for each block (Figure 3, main 
manuscript). 
Beat-to-beat data processing: 
1. Atrial fibrillation detection. We used a modified method of non-empty-cells described by Lian et 
al(10). A sliding window size of 128 beats was chosen with the window sliding/shifting by a 
single beat across time. As such, each beat was covered by 128 consecutive sliding windows 
containing 128 consecutive beats. For each beat the RR interval in milliseconds (ms) was noted. 
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The differential RR interval (dRR), also in ms, was also calculated for each beat by subtracting 
the RR interval at any particular beat by the RR interval of the preceding beat. The (RR, dRR) 
pair of each beat is then graphed on a 2-D plot with RR on the x-axis and dRR on the y-axis. The 
plot was then segmented into squares or "cells" that are 25 by 25 ms in size. The number of cells 
that contain at least 1 pair of (RR, dRR) is defined as a non-empty cell (NEC). The number of 
NECs is the surrogate for the degree of irregularity with higher NECs correlating with higher 
degree of irregularity and higher probability of atrial fibrillation. In order to determine an optimal 
threshold to define a point as being atrial fibrillation (both number of NECs and number of 
sliding windows including that point), we annotated atrial fibrillation episodes in 117 cases and 
117 controls. We then performed 700 iterations of random sampling, with replacement, from 
these cases/controls and calculated the F1 statistic (which balances sensitivity and positive 
predictive value) using every combination of NEC and number of windows. We then compiled 
this data to determine the optimal threshold over the 700 iterations. We found that the optimal F1 
statistic was obtained with a threshold of 52 NEC and 100% of windows, with an F1 value of 
0.87 (Sensitivity 92.4%, Specificity 97.5%, PPV 81.6%, NPV 99.1%).  
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SUPPLEMENTAL FIGURE 1 
Averaged-beat ECG parameter filters. The examples shown are for PR interval data from different 
patients. Points that are labeled blue are retained following application of the filter while points labeled 
red were removed from further analysis. Green markings represent calculations made for filtering. Panels 
A. Median filter for reducing signal noise, B. Tachyarrhythmia filter to remove segments of 
noncomparable data due to tachyarrhythmias, C. Pacer dependence filter removes segments of paced data 
from analysis, 4. Continuity filter removes significant outlier points which are likely artefactual. Data 
points for cases more than 24 hours from arrest are shown here only for illustration purposes of filters. 
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SUPPLEMENTAL FIGURE 2 
Random Forest Importance Plot. This shows the 15 variables with the highest importance in the 
random forest, based on mean decrease in the Gini coefficient (measure of how much each variable 
contributes to homogeneity of the nodes and leaves in the random forest). Higher values signify higher 
importance of the variable. 
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ST Lead V2 Δyn-(n-1)+ 
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SUPPLEMENTAL FIGURE 3 
Receiver Operating Characteristics Curves for the Model Development Set.  
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SUPPLEMENTAL FIGURE 4 
Receive Operating Characteristic Curves for Model Testing on Case block 1 vs. Case block 2. Block 
1 is the 3-hour block immediately preceding in-hospital cardiac arrest, while Block 2 is the 3-hour block 
preceding block 1. Only blocks from case patients are included in this analysis. Block 1 is considered 
true-positive for in-hospital cardiac arrest, while block 2 is considered false-positive for cardiac arrest. 
The red (X) marks the sensitivity and specificity at the threshold chosen based on the validation set. AUC 
= area under the curve. 
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SUPPLEMENTAL FIGURE 5 
Receive Operating Characteristic Curves for Model Testing on Validation Case block 1 vs. Control 
block 2. Block 1 is the 3-hour block immediately preceding in-hospital cardiac arrest, while Block 2 is 
the 3-hour block preceding block 1. Validation set case block 1 and all control block 2 are included in this 
analysis. The red (X) marks the sensitivity and specificity at the threshold chosen based on the validation 
set. AUC = area under the curve. 
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SUPPLEMENTAL FIGURE 6 
Receive Operating Characteristic Curves for Model Testing on Case block 2 vs. Validation set 
Control block 1. Block 1 is the 3-hour block immediately preceding in-hospital cardiac arrest, while 
Block 2 is the 3-hour block preceding block 1. All case block 2 and validation set control block 1 are 
included in this analysis. AUC = area under the curve. 
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SUPPLEMENTAL FIGURE 7 
Receive Operating Characteristic Curves for Model Testing on Case block 2 vs. Control block 2. 
Block 1 is the 3-hour block immediately preceding in-hospital cardiac arrest, while Block 2 is the 3-hour 
block preceding block 1. All case block 2 and all control block 2 are included in this analysis. AUC = 
area under the curve. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 39 
 
SUPPLEMENTAL TABLE 1 
Significant Univariate analyses, Development Set (Case block 1 vs. Control block 1)  
Variable OR Estimate* AUC 
Slope†   
 QRSd Δy1+/Δx1+ 1.3 (1.04 – 1.5) 0.587 
 QRSd Δy1-/Δx1- 1.4 (1.2 – 1.6) 0.611 
 QTc Δy1-/Δx1- 1.06 (1.00 – 1.1) 0.557 
 ST lead II Δy1+/Δx1+ 1.5 (1.1 – 1.9) 0.677 
 ST lead II Δy1-/Δx1- 1.5 (1.2 – 1.9) 0.667 
 ST lead V2 Δy1+/Δx1+ 1.8 (1.2 – 2.7) 0.620 
 ST lead V2 Δy1-/Δx1- 1.6 (1.02 – 2.5) 0.603 
Trend†   
 QRS amplitude Δy1- 1.3 (1.04 – 1.7) 0.562 
 QRSd Δy1+ 2.4 (1.8 – 3.0) 0.677 
 QRSd Δy1- 1.6 (1.3 – 2.1) 0.600 
 QTc Δy1+ 1.1 (1.04 – 1.2) 0.620 
 QTc Δy1- 1.2 (1.1 – 1.3) 0.664 
 RR Δy1+ 1.4 (1.1 – 1.7) 0.552 
 ST lead II Δy1+ 1.7 (1.3 – 2.2) 0.684 
 ST lead II Δy1- 2.0 (1.5 – 2.6) 0.698 
 ST lead V2 Δy1+ 2.3 (1.4 – 3.7) 0.634 
 ST lead V2 Δy1- 3.3 (1.8 – 6.0) 0.672 
Slope Comparison   
 QRSd Δy1+/Δx1+- Δy2+/Δx2+ 1.3 (1.1 – 1.6) 0.605 
 QRSd Δy1-/Δx1-- Δy2-/Δx2- 1.5 (1.2 – 1.8) 0.631 
 ST lead II Δy1+/Δx1+- Δy2+/Δx2+ 1.4 (1.06 – 1.9) 0.611 
 ST lead II Δy1-/Δx1-- Δy2-/Δx2- 1.6 (1.2 – 2.1) 0.609 
 ST lead V2 Δy1+/Δx1+- Δy2+/Δx2+ 1.5 (1.02 – 2.2) 0.572 
Trend Comparison   
 QRS amplitude Δy1-2- 1.5 (1.1 – 1.9) 0.577 
 QRSd Δy1-2+ 2.4 (1.8 – 3.3) 0.661 
 QRSd Δy1-2- 1.7 (1.3 – 2.3) 0.617 
 QTc Δy1-2+ 1.1 (1.01 – 1.2) 0.602 
 QTc Δy1-2- 1.1 (1.04 – 1.3) 0.597 
 RR Δy1-2+ 1.7 (1.3 – 2.2) 0.632 
 ST lead II Δy1-2+ 1.9 (1.3 – 2.9) 0.625 
 ST lead II Δy1-2- 2.2 (1.4 – 3.3)  0.629 
 ST lead V2 Δy1-2+ 1.8 (1.1 – 3.0) 0.599 
 ST lead V2 Δy1-2- 3.8 (1.7 – 8.4) 0.681 
Arrhythmias   
 Afib, any in block 1 2.0 (1.2 – 3.3)  
 Afib present block 1 not block 2 4.4 (2.2 – 8.8)  
 2° HB, any in block 1 2.6 (1.6 – 4.2)  
 2° HB present block 1 not block 2 3.8 (2.2 – 6.3)  
 Pauses, any in block 1 1.8 (1.1 – 2.9)  
 Pauses present block 1 not block 2 2.0 (1.2 – 3.5)  
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* OR for QRSd and QTc are shown per 10ms change (trend change) or 10ms/hr (slope). OR for QRS 
amplitude, ST lead II, and ST lead V2 are shown per 0.1mV change (trend change) or 0.1mV/hr 
(slope).  OR for RR is shown per 100ms change (trend change) or 100ms/hr (slope) 
† All OR for slopes and trend changes are reported for absolute values of the parameter.  
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SUPPLEMENTAL TABLE 2 
Electrocardiographic parameter summary for block 2  
 Case (n = 71‡) Control (n = 1679‡) p-value 
Arrhythmias, n(%)    
 AF, any in block 2 17 (24%) 365 (22%) NS 
 AF, present block 2 not block 3 3 (4%) 74 (4%) NS 
 2° HB, any in block 2 7 (10%) 309 (18%) NS 
 2° HB, present block 2 not block 3 3 (4%) 153 (9%) NS 
 Pauses, any in block 2 8 (12%) 331 (20%) NS 
 Pauses, present block 2 not block 3 5 (7%) 207 (12%) NS 
Trend Slope (Δy2/Δx2)†, median (IQR) 
 QRS Amplitude Averaged + (µV/hr) 250 (114 – 541) 283 (134 – 609) NS 
 QRS Amplitude Averaged – (µV/hr) 199 (92 – 499) 281 (127 – 588) NS 
 PR Interval + (ms/hr)* 5.7 (3.1 – 17.7) 6.3 (3.4 – 12.2) NS 
 PR Interval – (ms/hr)* 5.2 (2.5 – 12.2) 6.4 (3.5 – 12.6) NS 
 QRS Duration + (ms/hr) 3.1 (1.7 – 6.3) 4.0 (1.6 – 8.3) NS 
 QRS Duration – (ms/hr) 3.6 (1.8 – 8.2) 3.5 (1.4 – 7.7) NS 
 QTc + (ms/hr) 13.0 (7.3 – 23.9) 13.7 (7.2 – 26.7) NS 
 QTc – (ms/hr) 12.4 (6.3 – 35.7) 12.5 (6.7 – 23.4) 0.023 
 RR + (ms/hr) 33.1 (13.3 – 63.4) 48.4 (24.8 – 92.7) 0.031 
 RR – (ms/hr) 28.9 (14.3 – 65.3) 54.7 (24.7 – 110.8) NS 
 ST Lead II + (µV/hr) 20.8 (8.6 – 40.1) 14.8 (7.5 – 28.6) NS 
 ST Lead II – (µV/hr) 19.6 (10.4 – 33.9) 14.6 (8.1 – 29.1) NS 
 ST Lead V2 + (µV/hr) 12.6 (6.6 – 28.3) 10.0 (5.1 – 20.3) 0.012 
 ST Lead V2 – (µV/hr) 12.2 (6.3 – 23.2) 10.5 (5.4 – 20.1) NS 
Trend Slope Comparison (Δy2/Δx2 – Δy3/Δx3) †, median (IQR) 
 QRS Amplitude Averaged + (µV/hr) 8 (-149 – 187) 8 (-228 – 241) NS 
 QRS Amplitude Averaged – (µV/hr) 24 (-162 – 159) -3 (-216 – 194) NS 
 PR Interval + (ms/hr)* -0.8 (-3.8 – 5.9) -0.1 (-5.2 – 4.4) NS 
 PR Interval – (ms/hr)* -0.3 (-5.8 – 3.9) 0.0 (-5.0 – 4.5) NS 
 QRS Duration + (ms/hr) 0.3 (-3.2 – 2.1) 0.0 (-3.6 – 3.8) NS 
 QRS Duration – (ms/hr) 0.4 (-2.7 – 3.2) -0.2 (-3.8 – 3.1) NS 
 QTc + (ms/hr) 0.3 (-7.2 – 12.2) -0.2 (-10.3 – 10.5) NS 
 QTc – (ms/hr) -2.6 (-13.0 – 21.2) -1.0 (-10.9 – 8.0) 0.014 
 RR + (ms/hr) 0.2 (-16.8 – 33) -3.0 (-40 – 33) NS 
 RR – (ms/hr) -0.5 (-16.9 – 16.9) -0.4 (-43.7 – 41.8) NS 
 ST Lead II + (µV/hr) -1.1 (-13.1 – 21.6) -0.1 (-10.4 – 10.9) NS 
 ST Lead II – (µV/hr) 2.3 (-13.6 – 12.8) -0.2 (-11.2 – 10.6) NS 
 ST Lead V2 + (µV/hr) 0.9 (-10.8 – 14.8) -0.5 (-8.1 – 6.7) NS 
 ST Lead V2 – (µV/hr) 3.4 (-6.0 – 13.8) -0.5 (-8.4 – 7.5) NS 
Trend Change (Δy2) †, median (IQR) 
 QRS Amplitude Averaged + (µV) 79 (41 – 159) 86 (44 – 159) NS 
 QRS Amplitude Averaged – (µV) 64 (26 – 126) 83 (44 – 143) 0.041 
 PR Interval + (ms)* 7.5 (4 – 17) 7 (4 – 13) NS 
 PR Interval – (ms)* 6 (3 – 13) 7 (4 – 14) NS 
 QRS Duration + (ms) 4 (2 – 11) 4 (2 – 8) NS 
 QRS Duration – (ms) 4 (2 – 9) 4 (2 – 8) NS 
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 QTc + (ms) 16.3 (7.7 – 35.6) 14.3 (8.2 – 26.2) NS 
 QTc – (ms) 15.6 (8.3 – 40.4) 14.6 (8.5 – 25.7) 0.013 
 RR + (ms) 35 (16 – 70) 59 (30 – 106) 0.023 
 RR – (ms) 33 (21 – 63) 56 (30 – 105) 0.017 
 ST Lead II + (µV) 19 (9 – 41) 16 (9 – 29) 0.006 
 ST Lead II – (µV) 20 (12 – 45) 16 (9 – 28) NS 
 ST Lead V2 + (µV) 14 (8 – 28) 11 (6 – 20) 0.002 
 ST Lead V2 – (µV) 12 (6 – 22) 11 (6 – 20) NS 
Trend Change Comparison (Δy2-3) †, median (IQR) 
 QRS Amplitude Averaged + (µV) 0 (-38 – 66) 0 (-62 – 59) 0.042 
 QRS Amplitude Averaged – (µV) 11 (-59 – 48) 2 (-43 – 50) NS 
 PR Interval + (ms)* 0 (-5 – 5) 0 (-4 – 4) NS 
 PR Interval – (ms)* 0 (-3 – 6) 0 (-5 – 4) NS 
 QRS Duration + (ms) 0 (-4 – 4) 0 (-3 – 3) NS 
 QRS Duration – (ms) -1 (-6 – 2) 0 (-3 – 3) NS 
 QTc + (ms) 2.6 (-9.3 – 13.1) -0.4 (-9.7 – 8.0) NS 
 QTc – (ms) -2.6 (-9.2 – 15.0) 0.0 (-9.6 – 9.3) 0.031 
 RR + (ms) -9 (-40 – 23) -1 (-37 – 32) NS 
 RR – (ms) -8 (-29 – 13) 1 (-39 – 34) NS 
 ST Lead II + (µV) 0 (-12 – 15) 0 (-10 – 10) NS 
 ST Lead II – (µV) 4 (-5 – 12) 0 (-10 – 9) NS 
 ST Lead V2 + (µV) -1 (-12 – 10) 0 (-7 – 6) NS 
 ST Lead V2 – (µV) 0 (-7 – 10) 0 (-7 – 6) NS 
*Reported where measureable given this is not measureable in atrial fibrillation 
†For each row, + denotes the measure for the dominant positive trend, and – denotes the measure for 
the dominant negative trend for that ECG parameter. All negative trend change and slope 
measurements are reported as the absolute value.  
‡This reflects the number of patients with both block 2 and block 3 available. 6 case patients and 104 
control patients who had both block 1 and 2 were missing a block 3 
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SUPPLEMENTAL TABLE 3 
Multivariable Logistic Regression Models 
  OR (95% CI) * p-value 
Logistic Backward Stepwise   
 Atrial fibrillation (present block n, not block n-1) 3.7 (1.5 – 9.0) <0.001 
 2° HB (present block n, not block n-1) 4.6 (2.4 – 9.0) <0.001 
 QRSd Δyn
+/Δxn
+  0.62 (0.39 – 0.97) 0.032 
 QRSd Δyn
+  3.1 (1.9 – 5.1) <0.001 
 QTc Δyn
-  1.1 (1.06 – 1.2) <0.001 
 RR Δyn-(n-1)
+  1.5 (1.2 – 2.0) 0.002 
 ST Lead V2 Δyn-(n-1)
-  4.6 (1.8 – 11.7) 0.001 
Logistic Forward Stepwise   
 Atrial fibrillation (present block n, not block n-1) 3.9 (1.6 – 9.5) 0.002 
 2° HB (present block n, not block n-1) 4.8 (2.5 – 9.4) <0.001 
 QRSd Δyn
+/Δxn
+  0.63 (0.40 – 0.99) 0.044 
 QRSd Δyn
+  2.9 (1.7 – 4.8) <0.001 
 QTc Δyn
-  1.1 (1.0 – 1.2) 0.002 
 RR Δyn-(n-1)
+  1.5 (1.1 – 2.0) 0.002 
 ST Lead II Δyn-(n-1)
+  1.7 (1.01 – 2.8) 0.043 
 ST Lead V2 Δyn-(n-1)
-  4.4 (1.7 – 11.6) 0.002 
Block n is the 3-hour block being evaluated. Block n-1 is the preceding 3-hour block. 
 
* OR for QRSd and QTc are shown per 10ms change (trend change) or 10ms/hr (slope). OR for ST 
lead II and ST lead V2 are shown per 0.1mV change (trend change) or 0.1mV/hr (slope).  OR for RR is 
shown per 100ms change (trend change) or 100ms/hr (slope) 
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